您的位置: 首页 > 农业专利 > 详情页

Ferric citrate for reducing cardiac failure in chronic kidney disease patients
专利权人:
Keryx Biopharmaceuticals; Inc.
发明人:
Poradosu, Enrique,Bentsur, Ron,Oliviero III, James F.
申请号:
AU2014341975
公开号:
AU2014341975A1
申请日:
2014.11.03
申请国别(地区):
AU
年份:
2016
代理人:
摘要:
Methods of administering ferric citrate to reduce and/or control serum phosphorus levels, increase serum bicarbonate levels, improve one or more iron storage parameters (e.g., increase serum ferritin levels, increase transferrin saturation (TSAT), increase hemoglobin concentration), increase iron absorption, maintain iron stores, treat iron deficiency, treat anemia, reduce the need for IV iron, reduce the need for erythropoiesis-stimulating agents (ESAs), and/or reduce mortality and morbidity related to adverse cardiac events in chronic kidney disease patients, are disclosed.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充